Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Ottawa Hospital Research Institute
$105,000.00
Mesenchymal Stromal Cells to Treat Lung and Brain Injury in a Novel Triple-Hit Neonatal Mouse Model of Chronic Lung Disease
EF 2016-17
Résumé
An estimated 29 000 infants are born premature (<37 weeks) in Canada each year. Infants born extremely premature (<28 weeks) have lungs that are too weak to support their own breathing. The only life-saving option available is to administer oxygen and mechanically ventilate their lungs. Close to 40% of premature infants receiving this treatment develop a life-threatening disease called bronchopulmonary dysplasia (BPD). Infants with BPD have underdeveloped, weak lungs compared to healthy full-term babies. Babies with BPD are also at a high risk of brain damage, which can lead to difficulties walking, seeing, hearing, and learning. The most common brain injury occurs around the ventricles, one of the main areas where brain stem cells are found after birth. Brain stem cells are important because they can make new brain cells. It is unknown whether brain stem cells are damaged in BPD. To date, there is no treatment for BPD. Our lab has shown that stem cells from human umbilical cord can protect the lungs in a BPD rodent model. The purpose of this project is to determine whether brain stem cells are injured in a BPD mouse model and if so, to test whether human umbilical cord stem cell therapy can protect not only the lungs, but also the brain. To this end, we will compare the brain stem cells from our BPD-like mice with those from normal, healthy mice. We will also investigate whether brain stem cell injury correlates with deficits in learning and motor function by using mouse behavioural tests. In the final set of experiments, we will test whether umbilical cord stem cells prevent lung and brain injury in our BPD mouse model, so as to preserve normal behavioural function. This study will be the first to examine brain stem cells to explain the link between BPD and brain damage. Further, this work may provide a strong rationale for testing umbilical cord stem cell therapy in the clinic to reduce the life-threatening complications of extreme prematurity.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
365459
Name
Lithopoulos Marissa A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Mesenchymal Stromal Cells to Treat Lung and Brain Injury in a Novel Triple-Hit Neonatal Mouse Model of Chronic Lung Disease
Programtype2
Studentship Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bronchopulmonary Dysplasia; Cell Culture; Gene Expression; Immunohistochemistry; Neonatal Brain Injury; Neural Progenitor Cells; Neurobehavioural Tests; Neurodevelopment; Prematurity; Umbilical Cord Mesenchymal Stromal Cells
Abstract
An estimated 29 000 infants are born premature (<37 weeks) in Canada each year. Infants born extremely premature (<28 weeks) have lungs that are too weak to support their own breathing. The only life-saving option available is to administer oxygen and mechanically ventilate their lungs. Close to 40% of premature infants receiving this treatment develop a life-threatening disease called bronchopulmonary dysplasia (BPD). Infants with BPD have underdeveloped, weak lungs compared to healthy full-term babies. Babies with BPD are also at a high risk of brain damage, which can lead to difficulties walking, seeing, hearing, and learning. The most common brain injury occurs around the ventricles, one of the main areas where brain stem cells are found after birth. Brain stem cells are important because they can make new brain cells. It is unknown whether brain stem cells are damaged in BPD. To date, there is no treatment for BPD. Our lab has shown that stem cells from human umbilical cord can protect the lungs in a BPD rodent model. The purpose of this project is to determine whether brain stem cells are injured in a BPD mouse model and if so, to test whether human umbilical cord stem cell therapy can protect not only the lungs, but also the brain. To this end, we will compare the brain stem cells from our BPD-like mice with those from normal, healthy mice. We will also investigate whether brain stem cell injury correlates with deficits in learning and motor function by using mouse behavioural tests. In the final set of experiments, we will test whether umbilical cord stem cells prevent lung and brain injury in our BPD mouse model, so as to preserve normal behavioural function. This study will be the first to examine brain stem cells to explain the link between BPD and brain damage. Further, this work may provide a strong rationale for testing umbilical cord stem cell therapy in the clinic to reduce the life-threatening complications of extreme prematurity.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lithopoulos, Marissa A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~